Abstract
Background: The eosinophil/neutrophil/platelet-to-lymphocyte ratios (ELR, NLR, and PLR) have been used as clinical markers of systemic inflammation. However, they have not yet been tested in various subtypes of immediate hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs). Objectives: To assess the ELR, NLR, and PLR in various types of hypersensitivity to NSAIDs. Materials and Methods: A retrospective analysis of complete blood cell count and the ELR, NLR, and PLR was performed. Appropriate types of hypersensitivity to NSAIDs were diagnosed based on the anamnesis and drug provocation tests. The analysis covered 97 patients. Twenty were diagnosed with NERD (NSAID-exacerbated respiratory disease), 20 with NECD (NSAID-exacerbated cutaneous disease), 38 with NIUA (NSAID-inducted urticaria/angioedema), and 19 with SNIUAA (single-NSAID-induced urticaria/angioedema or anaphylaxis). Two controls groups were included: the first covered 15 patients with bronchial asthma and the second 28 patients with chronic spontaneous urticaria without NSAID hypersensitivity. Results: The NLR did not differ significantly between the NSAID hypersensitivity types. The ELR was significantly higher in NERD patients, and the PLR was significantly lower in NECD patients than in patients with other types of NSAID hypersensitivity and in controls. Conclusions: The ELR and PLR may be useful in differentiating various types of immediate hypersensitivity to NSAIDs. Moreover, the ELR may be helpful in differentiating patients with bronchial asthma with and without NSAID hypersensitivity and PLR in differentiating patients with chronic spontaneous urticaria from NECD.
References
1.
Doña
I
, Blanca-López
N
, Torres
MJ
, García-Campos
J
, García-Núñez
I
, Gómez
F
, et al. Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients
. J Investig Allergol Clin Immunol
. 2012
;22
(5
):363
–71
.2.
WHO
. International drug monitoring: the role of national centres. Report of a WHO meeting
. World Health Organ Tech Rep Ser
. 1972
;498
:1
–25
.3.
Demoly
P
, Adkinson
NF
, Brockow
K
, Castells
M
, Chiriac
AM
, Greenberger
PA
, et al. International consensus on drug allergy
. Allergy
. 2014 Apr
;69
(4
):420
–37
. 4.
Kowalski
ML
, Asero
R
, Bavbek
S
, Blanca
M
, Blanca-Lopez
N
, Bochenek
G
, et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs
. Allergy
. 2013 Oct
;68
(10
):1219
–32
. 5.
Stevenson
DD
, Sanchez-Borges
M
, Szczeklik
, A
. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes
. Ann Allergy Asthma Immunol
. 2001 Sep
; 87
(3
):177
–80
. 6.
Li
X
, Ma
X
, Tang
L
, Wang
B
, Chen
L
, Zhang
F
, et al. Prognostic value of neutrophil-to-lymphocyte ratio in urothelial carcinoma of the upper urinary tract and bladder: a systematic review and meta-analysis
. Oncotarget
. 2017 Sep
;8
(37
):62681
–92
. 7.
Holub
K
, Biete
A
. New pre-treatment eosinophil-related ratios as prognostic biomarkers for survival outcomes in endometrial cancer
. BMC Cancer
. 2018 Dec
;18
(1
):1280
. 8.
Ferro
M
, Musi
G
, Serino
A
, Cozzi
G
, Mistretta
FA
, Costa
B
, et al. Neutrophil, platelets, and eosinophil to lymphocyte ratios predict Gleason score upgrading in low-risk prostate cancer patients
. Urol Int
. 2019
;102
(1
):43
–50
. 9.
Arbel
Y
, Finkelstein
A
, Halkin
A
, Birati
EY
, Revivo
M
, Zuzut
M
, et al. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography
. Atherosclerosis
. 2012 Dec
;225
(2
):456
–60
. 10.
Duffy
BK
, Gurm
HS
, Rajagopal
V
, Gupta
R
, Ellis
SG
, Bhatt
DL
. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention
. Am J Cardiol
. 2006 Apr
;97
(7
):993
–6
. 11.
Coban
AM
, Aksoy
E
, Duman
D
, Özmen
I
, Yıldırum
E
, Güngör
S
, et al. Does eosinophilia and neutrophil to lymphocyte ratio affect hospital re-admission in cases of COPD exacerbation?
Tuber Toraks
. 2017 Dec
;65
(4
):282
–90
.12.
Tunçay
EA
, Karakurt
Z
, Aksoy
E
, Saltürk
C
, Gungor
S
, Ciftaslan
N
, et al. Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker
. Int J Chron Obstruct Pulmon Dis
. 2017 Nov
;12
: 3361
–70
.13.
Fu
H
, Qin
B
, Hu
Z
, Ma
N
, Yang
M
, Wei
T
, et al. Neutrophil- and platelet-to-lymphocyte ratios are correlated with disease activity in rheumatoid arthritis
. Clin Lab
. 2015
;61
(3–4
):269
–73
. 14.
Gasparyan
AY
, Ayvazyan
L
, Mukanova
U
, Yessirkepov
M
, KItas
GD
. The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases
. Ann Lab Med
. 2019 Jul
;39
(4
):345
–57
. 15.
Brescia
G
, Pedruzzi
B
, Barion
U
, Cinetto
F
, Giacomelli
L
, Martini
A
, et al. Are neutrophil-, eosinophil-, and basophil-to-lymphocyte ratios useful markers for pinpointing patients at higher risk of recurrent sinonasal polyps?
Am J Otolaryngol
. 2016 Jul-Aug
;37
(4
):339
–45
. 16.
Kara
A
, Guven
M
, Yilmaz
MS
, Demir
D
, Elden
H
. Are neutrophil, platelet and eosinophil-to-lymphocyte ratio and red blood cell distribution width can be used for nasal polyposis?
Eur Arch Otorhinolaryngol
. 2018 Feb
;275
(2
):409
–13
. 17.
Tecimer
SH
, Kasapoglu
F
, Demir
UL
, Ozmen
OA
, Coskun
H
, Basut
O
. Correlation between clinical findings and eosinophil/neutrophil ratio in patients with nasal polyps
. Eur Arch Otorhinolaryngol
. 2015 Apr
;272
(4
):915
–21
. 18.
Mochimaru
T
, Ueda
S
, Suzuki
Y
, Asano
K
, Fukunaga
K
. Neutrophil-to-lymphocyte ratio as a novel independent predictor of severe exacerbation in patients with asthma
. Ann Allergy Asthma Immunol
. 2018 Mar
;122
(3
):337
–39.e1
.19.
Gungen
AC
, Aydemir
Y
. The correlation between asthma disease and neutrophil to lymphocyte ratio
. Res J Allergy Immunol
. 2017 Aug
;1
(1
):1
–4
.20.
Yenigun
A
, Sezen
S
, Calim
OF
, Ozturan
O
. Evaluation of the eosinophil-to-lymphocyte ratio in pediatric patients with allergic rhinitis
. Am J Rhinol Allergy
. 2016 Mar-Apr
:30
(2
);e21
–5
. 21.
Brockow
K
, Przybilla
B
, Aberer
W
, Bircher
AJ
, Brehler
R
, Dickel
H
, et al. Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergologists (AeDA), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology (ÖGAI), the German Academy of Allergology and Environmental Medicine (DAAU), the German Center for Documentation of Severe Skin Reactions and the German Federal Institute for Drugs and Medical Products (BfArM)
. Allergo J Int
. 2015
;24
(3
):94
–105
. 22.
Kowalski
ML
, Makowska
JS
. Seven steps to the diagnosis of NSAIDs hypersensitivity: how to apply a new classification in real practice?
Allergy Asthma Immunol Res
. 2015 July
:7
(4
);312
–20
. 23.
Niżankowska-Mogilnicka
E
, Bochenek
G
, Mastalerz
L
, Świerczyńska
M
, Picado
C
, Scadding
G
, et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity
. Allergy
. 2007
:62
(10
);1111
–8
.24.
Vena
GA
, Cassano
N
, Marzano
AV
, Asero
R
. The role of platelets in chronic urticaria
. Int Arch Allergy Immunol
. 2016
:169
(2
);71
–9
. 25.
Palikhe
S
, Palikhe
NS
, Kim
SH
, Yoo
HS
, Shin
YS
, Park
HS
. Elevated platelet activation in patients with chronic urticaria: a comparison between aspirin-intolerant and aspirin-tolerant groups
. Ann Allergy Asthma Immunol
. 2014 Sep
:113
(3
);276
–81
. © 2020 S. Karger AG, Basel
2020
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
